SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2017
Prana Biotechnology Limited
(Name of Registrant)
Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____
This Form 6-K is being incorporated by reference into the Registrant’s Registration Statements on Form F-3 (File No. 333-199783) and Form S-8 (File No. 333-153669).
PRANA BIOTECHNOLOGY LIMITED
| 6-K | Items |
| 1. |
RESULTS OF ANNUAL GENERAL MEETING |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| PRANA BIOTECHNOLOGY LIMITED | |||
| (Registrant) | |||
| By: | /s/ Geoffrey Kempler | ||
| Geoffrey Kempler, | |||
| Executive Chairman | |||
November 16, 2017
COMPANY ANNOUNCEMENT
(ASX: PBT)
RESULTS OF ANNUAL GENERAL MEETING
Friday, 17th November 2017
The Company wishes to advise that all resolutions contained in the Notice of Meeting were carried on a show of hands.
In accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, the following information is provided in relation to the proxy votes received for each resolution considered by Members of the Company at the Annual General Meeting held today at 09.30am.
| Resolutions | For | Against | Abstain | Proxy's Discretion* | Total Valid Proxies Received | For Percentage | |
| 1 | Adoption of Remuneration Report | 42,331,711 | 4,820,686 | 5,044,503 | 4,346,323 | 56,543,223 | 90.64% |
| 2 | Re-election of Director – Mr Peter Marks | 62,806,252 | 4,817,068 | 2,028,480 | 4,365,089 | 74,016,889 | 93.31% |
| 3 | Re-election of Director – Lawrence Gozlan | 64,302,052 | 3,301,608 | 2,038,140 | 4,375,089 | 74,016,889 | 95.41% |
| 4 | Re-election of Director – Prof Ira Shoulson | 65,216,002 | 2,336,488 | 2,098,860 | 4,365,539 | 74,016,889 | 96.75% |
| 5a | Issue of Unquoted Options to Mr Geoffrey Kempler | 40,658,460 | 9,896,420 | 1,849,620 | 4,138,723 | 56,543,223 | 81.91% |
| 5b | Issue of Unquoted Options to Mr Brian Meltzer | 39,939,312 | 10,510,558 | 1,954,630 | 4,138,723 | 56,543,223 | 80.75% |
| 5c | Issue of Unquoted Options to Mr Peter Marks | 39,907,122 | 10,506,678 | 1,986,700 | 4,142,723 | 56,543,223 | 80.74% |
| 5d | Issue of Unquoted Options to Dr George Mihaly | 40,761,162 | 9,743,978 | 1,848,360 | 4,189,723 | 56,543,223 | 82.18% |
| 5e | Issue of Unquoted Options to Mr Lawrence Gozlan | 39,880,662 | 10,506,638 | 1,995,200 | 4,160,723 | 56,543,223 | 80.74% |
| 5f | Issue of Unquoted Options to Prof Ira Shoulson | 40,726,602 | 9,946,538 | 1,731,360 | 4,138,723 | 56,543,223 | 81.85% |
| 6 | Approval of 10% Placement Issue | 57,817,324 | 10,089,881 | 1,742,095 | 4,148,923 | 73,798,223 | 86.00% |
* The Chairman voted undirected proxies in his control in favour of all resolutions.
** Note: Resolution 1 and 6 are special resolutions and required 75% approval to be passed. This threshold has been achieved and both resolutions passed.
On behalf of the Board
Phillip Hains
Company Secretary
Prana Biotechnology Limited
|
Level 3, 62 Lygon Street, Carlton Victoria Australia 3053 |
Page 1 of 1 |
Telephone: 61 3 9824 5254 Facsimile: 61 3 9822 7735 |